FDA urges sponsors to find alternatives to nonhuman primates for toxicity studies
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaPharmaceuticalsPreclinical studyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaPharmaceuticalsPreclinical study